Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;127(1):1-10.
doi: 10.1352/1944-7558-127.1.1.

Anxiety in Angelman Syndrome

Stacey C Grebe  1 , Danica L Limon  1 , Morgan M McNeel  1 , Andrew Guzick  1 , Sarika U Peters  2 , Wen-Hann Tan  3 , Anjali Sadhwani  3 , Carlos A Bacino  4 , Lynne M Bird  5 , Rodney C Samaco  6 , Leandra N Berry  7 , Wayne K Goodman  8 , Sophie C Schneider  9 , Eric A Storch  9
Affiliations

Anxiety in Angelman Syndrome

Stacey C Grebe et al. Am J Intellect Dev Disabil. .

Abstract

Angelman Syndrome (AS) is a neurodevelopmental disorder most commonly caused by the impaired expression of the maternal UBE3A gene on chromosome 15. Though anxiety has been identified as a frequently present characteristic in AS, there are limited studies examining anxiety in this population. Studies of anxiety in other neurodevelopmental disorders have found disorder specific symptoms of anxiety and age specific displays of anxiety symptoms. However, there is a consistent challenge in identifying anxiety in people with neurodevelopmental disorders given the lack of measurement instruments specifically designed for this population. Given the limited information about AS and anxiety, the aims of the current project were to (a) examine symptoms of anxiety in children with AS and (b) determine the correlates of anxiety in children with AS. Participants included 42 adult caregivers of youth with AS in the AS Natural History study who completed the Developmental Behavior Checklist (DBC). The results found that 26% of the sample demonstrated elevated symptoms of anxiety and established a relationship between elevated anxiety in youth with AS and higher levels of irritability, hyperactivity, self-absorbed behaviors, and disruptive/antisocial behaviors. Findings from this research provide a foundation for tailoring evidence-based assessments and treatments for youth with AS and anxiety.

Keywords: Angelman syndrome; anxiety; children; developmental behavior checklist.

PubMed Disclaimer

References

    1. Achenbach TM, & Rescorla L (2001). Manual for the ASEBA school-age forms & profiles: An integrated system of multi-informant assessment. Aseba.
    1. Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, Eichele G, & Beaudet AL (1997). Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nature Genetics, 17(1), 75. 10.1038/ng0997-75 - DOI - PubMed
    1. Aman MG, Singh NN, Stewart AW, & Field CJ (1985). The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89(5), 485–91. 10.1037/t10453-000 - DOI - PubMed
    1. Bailey N (2007). Prevalence of psychiatric disorders in adults with moderate to profound learning disabilities. Advances in Mental Health and Learning Disabilities, 1(2), 36–44. 10.1108/17530180200700019 - DOI
    1. Bayley N (2005). Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). Harcourt Assessment, Inc.

Publication types